Iris Kim, ScD, is the Director of Pharmacoepidemiology and Safety at Gilead Sciences since 2025. Previously, they served as an Associate Director for Epidemiology Strategy at Bristol Myers Squibb from 2021 to 2025 and as a Sr. Manager in Clinical Epidemiology at Vertex Pharmaceuticals from 2019 to 2021. Iris has also held research positions at the National Institutes of Health and Massachusetts General Hospital, alongside academic roles as a Graduate Student Researcher and Teaching Assistant at Harvard T.H. Chan School of Public Health. They received their Doctor of Science in Epidemiology from Harvard and hold a Bachelor of Science in Human Development from Cornell University.
This person is not in any teams
This person is not in any offices